Preoperative hematological assessment of pediatric patients with cerebral palsy

Hakan Omeroğlu1, Ulukan Inan, Kemal Turgut

  • 1Department of Orthopedics and Traumatology, Faculty of Medicine, Eskiflehir Osmangazi University, Eskiflehir, Turkey. homeroglu@superonline.com

Insights

Routine preoperative blood tests in children with cerebral palsy (CP) undergoing orthopedic surgery are similar to those of other orthopedic patients. Advanced hematological testing is only recommended if initial results are abnormal.

Area of Science:

  • Pediatric Orthopedics
  • Hematology
  • Neurology

Background:

  • Children with cerebral palsy (CP) may experience hematological alterations due to nutritional deficiencies and antiepileptic drugs.
  • These alterations can increase the risk of intraoperative or postoperative complications.

Purpose of the Study:

  • To evaluate preoperative routine blood tests in pediatric CP patients undergoing orthopedic procedures.
  • To compare hematological status between CP patients with varying walking abilities and a control group.

Main Methods:

  • Retrospective study comparing 62 CP patients with 130 orthopedic controls.
  • Analysis of various hematological parameters including hemoglobin, hematocrit, WBC, and platelet counts.
  • Comparison between CP patients categorized by Gross Motor Function Classification System (GMFCS) levels I/II and III/IV.

Main Results:

  • No significant differences in preoperative hematological parameters were found between CP patients and the control group.
  • Hematological parameters were similar between CP patients with GMFCS levels I/II and III/IV.
  • No increased risk of hematological complications was identified in CP patients based on routine preoperative tests.

Conclusions:

  • Preoperative blood test results in pediatric CP patients undergoing orthopedic interventions are comparable to those of non-CP orthopedic patients.
  • Routine advanced preoperative hematological tests are not generally necessary for CP patients.
  • Consider advanced testing only for CP patients with initially abnormal blood test results.
Abstract